Multiple antimicrobial and immune-modulating activities of cysteamine in infectious diseases
Article in Biomedicine & Pharmacotherapy (July 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single center study
Preprint in medRxiv (July 2024)
Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination
Article in Annals of Clinical and Translational Neurology (May 2024)